Clopidogrel and metoprolol in myocardial infarction - Reply

Clopidogrel and metoprolol in myocardial infarction - Reply

Dettagli Bibliografici
Autori principali:	Chen, Z, Collins, R, Peto, R, Xie, J, Jiang, L, Liu, L
Natura:	Journal article
Pubblicazione:	2006

Documenti analoghi

COMMIT/CCS-2 Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study
di: Collins, R
Pubblicazione: (2005)

COMMIT/CCS-2 (Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study)
di: Chen, Z
Pubblicazione: (2005)

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
di: Chen, Z, et al.
Pubblicazione: (2005)

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
di: Chen, Z, et al.
Pubblicazione: (2005)

Clinical effects of anticoagulants in suspected acute myocardial infarction - Reply
di: Collins, R, et al.
Pubblicazione: (1997)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
di: Candice Volney, et al.
Pubblicazione: (2019-07-01)

INTRAVENOUS STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION - REPLY
di: Stampfer, M, et al.
Pubblicazione: (1983)

Effect of early metoprolol on infarct size in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial
di: Suraj Khanal
Pubblicazione: (2014-01-01)

Clopidogrel effectiveness in patients with ST elevation myocardial infarction
di: O. V. Sirotkina, et al.
Pubblicazione: (2009-02-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
di: B. N. Garifullin, et al.
Pubblicazione: (2016-01-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
di: B. N. Garifullin, et al.
Pubblicazione: (2016-01-01)

Authors' reply [5]
di: Chen, Z, et al.
Pubblicazione: (2006)

Magnesium in acute myocardial infarction.
di: Collins, R, et al.
Pubblicazione: (1997)

To study the clopidogrel pharmacogenetics in north Indian population with acute myocardial infarction
di: R.K. Sinha, et al.
Pubblicazione: (2017-11-01)

Ivabradine versus metoprolol in patients with acute inferior wall myocardial infarction – ‘Expanding arena for ivabradine’
di: R.K. Gokhroo, et al.
Pubblicazione: (2015-12-01)

Comparison of the early outcome of acute myocardial infarction in women and men - reply
di: Collins, R, et al.
Pubblicazione: (1998)

Magnesium theory in acute myocardial infarction.
di: Collins, R, et al.
Pubblicazione: (1996)

Modifying effect of diabetes on the short-term effect of clopidogrel in patients with myocardial infarction
di: Wuxiang Xie, et al.
Pubblicazione: (2018-01-01)

Acute myocardial infarction occurring while on chronic clopidogrel therapy ('clopidogrel failure') is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis.
di: Ehud Regev, et al.
Pubblicazione: (2018-01-01)

Neutrophil stunning by metoprolol reduces infarct size
di: Jaime García-Prieto, et al.
Pubblicazione: (2017-04-01)

Ivabradine versus metoprolol in patients with acute inferior wall myocardial infarction – ‘Expanding arena for ivabradine’
di: Kumari Priti
Pubblicazione: (2015-12-01)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
di: Samuel K. Peasah, et al.
Pubblicazione: (2023-12-01)

Pilot experience with clopidogrel in the treatment of an .ST-elevation acute myocardial infarction
di: S V Shalaev, et al.
Pubblicazione: (2004-06-01)

Interpretation of IST and CAST stroke trials - Reply
di: Chen, Z, et al.
Pubblicazione: (1997)

REDUCTION IN MORTALITY AFTER MYOCARDIAL-INFARCTION BY ACUTE INTERVENTION
di: Yusuf, S, et al.
Pubblicazione: (1983)

Cost-effectiveness and cost–utility analysis of the use of clopidogrel and pantoprazole in comparison with clopidogrel and omeprazole for the secondary prevention of myocardial infarction in Iran
di: Mohammadreza Amirsadri, et al.
Pubblicazione: (2021-01-01)

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
di: Karla N. Samman, et al.
Pubblicazione: (2021-06-01)

Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study
di: Køber Lars, et al.
Pubblicazione: (2010-01-01)

Frailty and Clinical Outcomes of Ticagrelor Versus Clopidogrel in Older Adults With Acute Myocardial Infarction
di: Darae Ko, et al.
Pubblicazione: (2024-08-01)

Effects of Folic Acid Plus Vitamin B-12 vs Placebo in Myocardial Infarction Survivors Reply
di: Armitage, J, et al.
Pubblicazione: (2010)

CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION
di: N. V. Teplova
Pubblicazione: (2016-03-01)

Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013
di: O. V. Averkov
Pubblicazione: (2013-02-01)

Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
di: Yong Kang Lee, et al.
Pubblicazione: (2023-08-01)

Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan
di: Chih-Kuo Lee, et al.
Pubblicazione: (2021-07-01)

The authors reply
di: Collins, R, et al.
Pubblicazione: (2009)

GISSI-2: 10% reduction in mortality with heparin in acute myocardial infarction?
di: Collins, R, et al.
Pubblicazione: (1990)

Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes
di: Carol T. Bussey, et al.
Pubblicazione: (2020-03-01)

LOW CHOLESTEROL AND CORONARY HEART-DISEASE - REPLY
di: Chen, Z, et al.
Pubblicazione: (1991)

Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
di: Second Chinese Cardiac Study (CCS-2) Collaborative Group
Pubblicazione: (2000)

REDUCTION IN MAJOR MORBIDITY AND MORTALITY BY HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
di: Macmahon, S, et al.
Pubblicazione: (1989)